CBS News Miami investigates the financial hurdles surrounding these medications and explores alternatives that may offer a ...

Weight-loss drug developer Metsera has raised $275 million after pricing its U.S. initial public offering at $18 per share, above its targeted range, the ARCH Venture Partners-backed biotech company ...

Weight-loss drugs are transforming health care and Wall Street, but exciting prospects don’t necessarily mean a company is a good investment.

A new poll from The -NORC Center for Public Affairs Research looks at what U.S. adults think about weight-loss drugs like Ozempic or Wegovy. (AP Video: Laura Bargfeld) ...

Salk scientists identify protein BCL6 as a key regulator of muscle maintenance in mice; BCL6-enhancing therapies may prevent ...

After the defeat, the Bills QB was clearly dejected. He was spotted by cameras looking upset on Buffalo’s sideline at the end ...

Java Burn is a specially formulated coffee booster for weight loss. With eight different ingredients designed to ignite the ...

Lizzo says she's feeling "happy" as she celebrates reaching her weight loss goal amid her fitness journey. "I haven't seen ...

GLP-1 medications associated with lower risks of Alzheimer's and heart disease, but higher risks of pancreatitis and kidney ...

A class of drugs designed to fight diabetes and weight loss can help with a host of other problems, but also carry some side effects.

Pharmaceutical giants Eli Lilly and Novo Nordisk, makers of Zepbound and Wegovy, respectively, have filed lawsuits against medical spas, weight-loss clinics, and compounding pharmacies they accuse of ...

Here are three Nets takeaways from Wednesday's worst loss in franchise history: The Nets came into Wednesday's game at the Clippers as double-digit underdogs and that was with the possibility of Cam ...